Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Therapeutic Erythrocytapheresis as Treatment for Hemochromatosis Patients.

NCT00202436 is registered in ClinicalTrials.gov with Sanquin Research & Blood Bank Divisions as lead sponsor.

NCT NCT00202436
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00202436 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Therapeutic Erythrocytapheresis as Treatment for Hemochromatosis Patients.
Lead sponsor
Sanquin Research & Blood Bank Divisions
Phase
Phase 3
Overall status
Completed
Start date
October 31, 2004
Completion date
September 30, 2009
Enrollment
40 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

hemochromatosis